BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.
复制标题
DOI:
10.1158/0008-5472.can-13-2611
复制
发表时间:
2014-05-15
期刊:
影响因子:
11.2
通讯作者:
Harkin DP
中科院分区:
文献类型:
--
作者:
Savage KI;Matchett KB;Barros EM;Cooper KM;Irwin GW;Gorski JJ;Orr KS;Vohhodina J;Kavanagh JN;Madden AF;Powell A;Manti L;McDade SS;Park BH;Prise KM;McIntosh SA;Salto-Tellez M;Richard DJ;Elliott CT;Harkin DP
Germline mutations in BRCA1 predispose carriers to a high incidence of breast and ovarian cancers. BRCA1 functions to maintain genomic stability through critical roles in DNA repair, cell cycle arrest and transcriptional control. A major question has been why BRCA1 loss or mutation leads to tumors mainly in estrogen-regulated tissues, given that BRCA1 has essential functions in all cell types. Here we report that estrogen and estrogen metabolites can cause DNA double strand breaks (DSB) in estrogen receptor-α negative breast cells and that BRCA1 is required to repair these DSBs to prevent metabolite-induced genomic instability. We found that BRCA1 also regulates estrogen metabolism and metabolite-mediated DNA damage by repressing the transcription of estrogen-metabolising enzymes, such as CYP1A1, in breast cells. Lastly, we used a knock-in human cell model with a heterozygous BRCA1 pathogenic mutation to show how BRCA1 haploinsufficiency affects these processes. Our findings provide pivotal new insights into why BRCA1 mutation drives the formation of tumours in estrogen-regulated tissues, despite the general role of BRCA1 in DNA repair in all cell types.